News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Not-So-Subtle Reason Behind Valeant (VRX)' 30% Rise In May



6/8/2017 6:43:52 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
What happened

Shares of Valeant Pharmaceuticals (NYSE:VRX), an embattled drugmaker known for growing by acquisition and raising prices on mature therapies, exploded 30% higher in May, according to data from S&P Global Market Intelligence. The reason for the surge in Valeant's share price can be traced to its better-than-expected first-quarter earnings release on May 9.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES